| Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center |
NCT00404547: Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The ACCEPT-study (BY9010/CA-102) |
|
|
| Completed | 4 | 1121 | Canada | Ciclesonide, Usual Care Inhaled Glucocorticosteroids | AstraZeneca | Asthma | 04/08 | 12/08 | | |
NCT00826969: Ciclesonide for the Treatment of Airway Hyperresponsiveness |
|
|
| Completed | 4 | 64 | Europe | Ciclesonide, Placebo | AstraZeneca | Asthma | 07/10 | 10/11 | | |
NCT01333800: Cost-effectiveness Study of Beclomethasone Versus Ciclesonide as Controller Medications in Pediatric Asthma |
|
|
| Completed | 4 | 94 | RoW | Beclomethasone, Ciclesonide | Grünenthal Colombiana S.A. | Asthma | 12/10 | 12/10 | | |
| Completed | 4 | 30 | Europe | Ciclesonide, Alvesco, Placebo | University of Nottingham, Nottingham University Hospitals NHS Trust, University Hospitals, Leicester | Asthma | 10/13 | 12/13 | | |
| Terminated | 4 | 6 | Canada | inhaled corticosteroid, Flovent; Pulmicort; Alvesco. | University of Alberta, GlaxoSmithKline | Asthma | 10/15 | 10/15 | | |
